Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HNF4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAV2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LINC01558 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC34A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRELP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACNA2D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGHV3-23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF130 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCP11L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANGPTL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL1RAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP13A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC30A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on